NCT00193375View on ClinicalTrials.gov

Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

May 31, 2008

Conditions

Lung Cancer

Interventions

DRUG

Irinotecan

50mg/m2 days 1 \& 8 each 21-day cycle 1 \& 2, 28-day cycle 3 \& 4

DRUG

Carboplatin

AUC 5

DRUG

Bevacizumab

10mg/kg IV every 2 weeks for 10 doses starting week 16

RADIATION

Radiation

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

collaborator

Pharmacia and Upjohn

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER